Elvina Almuradova, Associate Professor of Oncology at the European Institute of Oncology, shared a post on LinkedIn:

“Could breast cancer treatments impact Alzheimer’s risk?

A large Korean cohort study of 70,701 breast cancer survivors found that they had an 8% lower risk of developing Alzheimer’s disease compared with age-matched cancer-free women (SHR: 0.92).

Key findings:

• The reduced risk was more pronounced in women aged ≥65.
• Radiation therapy was significantly associated with lower AD risk (HR: 0.77).
• This protective association diminished after 5 years of survivorship.
• No significant association was found with anthracycline, taxane, trastuzumab, or endocrine therapies.

While cognitive impairment (“chemobrain”) remains a concern, this study suggests that standard breast cancer treatments may not increase – and may even lower – long-term AD risk.”

Title: Alzheimer Disease in Breast Cancer Survivors

Authors: Su-Min Jeong, Wonyoung Jung, Hyeonjin Cho, Hea Lim Choi, Keun Hye Jeon, Ki-Woong Nam, Yun-Gyoo Lee, Bongseong Kim, Kyungdo Han, Dong Wook Shin

Read Full Article.

Breast Cancer Treatments

Immunotherapy for Breast Cancer: Types, Success Rate, Side Effects & More

Elvina Almuradova: Could Breast Cancer Treatments Impact Alzheimer’s risk?

“Could breast cancer treatments impact Alzheimer’s risk?

A large Korean cohort study of 70,701 breast cancer survivors found that they had an 8% lower risk of developing Alzheimer’s disease compared with age-matched cancer-free women (SHR: 0.92).

Key findings:

While cognitive impairment (“chemobrain”) remains a concern, this study suggests that standard breast cancer treatments may not increase – and may even lower – long-term AD risk.”